TargetTyrosine-protein kinase ZAP-70(Homo sapiens (Human))
Preclinical Research Novartis
Curated by ChEMBL
Preclinical Research Novartis
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibition of binding to human ZAP-70 SH2 domainMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ZAP-70(Homo sapiens (Human))
Preclinical Research Novartis
Curated by ChEMBL
Preclinical Research Novartis
Curated by ChEMBL
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of binding to human ZAP-70 SH2 domainMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ZAP-70(Homo sapiens (Human))
Preclinical Research Novartis
Curated by ChEMBL
Preclinical Research Novartis
Curated by ChEMBL
Affinity DataIC50: 6.30E+4nMAssay Description:Inhibition of binding to human ZAP-70 SH2 domainMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ZAP-70(Homo sapiens (Human))
Preclinical Research Novartis
Curated by ChEMBL
Preclinical Research Novartis
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of binding to human ZAP-70 SH2 domainMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ZAP-70(Homo sapiens (Human))
Preclinical Research Novartis
Curated by ChEMBL
Preclinical Research Novartis
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of binding to human ZAP-70 SH2 domainMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ZAP-70(Homo sapiens (Human))
Preclinical Research Novartis
Curated by ChEMBL
Preclinical Research Novartis
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of binding to human ZAP-70 SH2 domainMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ZAP-70(Homo sapiens (Human))
Preclinical Research Novartis
Curated by ChEMBL
Preclinical Research Novartis
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of binding to human ZAP-70 SH2 domainMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ZAP-70(Homo sapiens (Human))
Preclinical Research Novartis
Curated by ChEMBL
Preclinical Research Novartis
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of binding to human ZAP-70 SH2 domainMore data for this Ligand-Target Pair